DABIGATRAN ETEXILATE ACCORD 110mg capsules
dabigatran etexilat Indicated for: prevention and treatment of thromboembolism
letter D · page 2
dabigatran etexilat Indicated for: prevention and treatment of thromboembolism
dabigatran etexilat Indicated for: prevention and treatment of thromboembolism
dabigatran etexilat Indicated for: prevention and treatment of thromboembolism
dabigatran etexilat Indicated for: prevention and treatment of thromboembolism
dabigatran etexilat Indicated for: prevention and treatment of thromboembolism
dabigatran etexilat Indicated for: prevention and treatment of thromboembolism
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
dacarbazine Indicated for: cancer
L01AX04 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
apomorphine Indicated for: Parkinson's disease
N04BC07 Nervous system | Dopaminergic agents | Dopamine agonists
apomorphine Indicated for: Parkinson's disease
N04BC07 Nervous system | Dopaminergic agents | Dopamine agonists
apomorphine Indicated for: Parkinson's disease
N04BC07 Nervous system | Dopaminergic agents | Dopamine agonists